Healthcare decisions depend on defensible, timely evidence. From regulatory filings to coverage negotiations, the ability to generate real-world insights quickly and at scale defines who advances and who falls behind.
Regulators expect more than retrospective data—they want scientifically sound answers grounded in real-world settings. Payers demand context and comparability, and life sciences companies are under pressure to demonstrate safety, effectiveness, and value across increasingly diverse populations.
Real-world evidence (RWE) is central to all of this. But to meet the moment, organizations need more than raw data or isolated tools—they need a secure, scalable platform that can turn complex scientific questions into reliable, decision-ready evidence.
That’s why we’re proud to announce that the Aetion Evidence Platform® (AEP) is now available in AWS Marketplace.
This launch gives customers a faster, cleaner way to integrate AEP into their existing AWS workflow. It removes friction from procurement, speeds up onboarding, and enables teams to start generating real-world evidence quickly, securely, and at enterprise scale. With the pairing of two trusted partners—Aetion and AWS—customers can operate within a familiar environment while gaining the speed, control, and transparency their decisions depend on.
AEP is trusted by global biopharma, payers, and regulators to generate decision-grade evidence—built on transparent methods, rooted in epidemiology, and ready for regulatory or HTA review. Whether optimizing clinical trials, supporting market access, or running post-market studies, AEP delivers the speed, scale, and scientific fidelity that today’s environment requires.
With AEP now available through AWS Marketplace, organizations can:
“Access to great technology shouldn’t slow down great science,” said Kevin Riley, President of Aetion. “We put AEP in AWS Marketplace to meet our customers where they already work—and to help them move faster when it matters most.”
Generating real-world evidence takes more than technical horsepower—it takes tools built for how scientists actually work. That’s where AetionAI comes in.
Through deep integration with Amazon Bedrock, AetionAI helps users define variables, identify patient subgroups, and iterate on analyses using natural language. These embedded generative AI features lower the barrier to exploration, allowing scientists, analysts, and strategists to work faster and more collaboratively.
“Our job is to meet customers where they are—scientifically, technically, and operationally,” said Katie Mues, PhD, MPH, VP & GM of Scientific Services at Aetion. “This launch provides our customers with the tools to apply rigorous epidemiologic methods at scale, ensuring that complex real-world data is transformed into meaningful outcomes that support regulatory decision-making.”
|
Stakeholder |
What AEP + AWS Marketplace Enables |
|
Clinical Development |
|
|
HEOR & Market Access |
|
|
Regulatory Affairs |
|
|
Payers & HTA Bodies |
|
|
Data Science & RWE Teams |
|
Aetion combines deep scientific expertise with robust technology to power decision-grade evidence generation. What sets us apart is more than methodology—it’s how we combine science, intelligence, and flexibility in one trusted platform.
We’re proud to support some of the most critical decisions in healthcare—through technology built to scale and science built to last.
The Aetion Evidence Platform® is now live in AWS Marketplace—ready for immediate deployment. Simplify your process, reduce friction, and accelerate your results like never before.